The aim of the research of the Advanced Drug Delivery and Biomaterials research group (ADDB) to develop new delivery systems for unmet medical and pharmaceutical needs that address two main challenges for the pharmaceutical industry.
modified on
10/08/2026
|
Louvain Drug Research Institute
The aim of the research of the Advanced Drug Delivery and Biomaterials research group is to develop new delivery systems for unmet medical and pharmaceutical needs that address two main challenges for the pharmaceutical industry, namely the delivery of i) biotech-based drugs (proteins, vaccines, nucleic acids) and ii) poorly water soluble drugs…
modified on
08/03/2025
|
Louvain Drug Research Institute
For what purpose | For Whom | Equipment | Access | Costs
modified on
07/01/2026
|
Center for High Performance Computing and Mass Storage
What is Open Access ? Open Access is defined as free access to scientific publications, enabling them to be reused and redistributed. In this way, scientific results are disseminated more widely, benefiting from reduced communication time and increased visibility.According to UNESCO, a publication is considered open access if :its content is…
modified on
20/01/2026
|
Les Bibliothèques - Learning centers de l'UCLouvain
Pharmacological evaluation of drugs covers complementary aspects, going from experimental pharmacology to optimization of drug usage in clinical practice via a characterization of patient's specificities that could affect pharmacokinetics or pharmacodynamics (clinical pharmacology).In this context, we conduct bidirectional translational research,…
modified on
10/08/2026
|
Louvain Drug Research Institute
Explore UCLouvain’s IT resources: user account, access card, technical support and student support services.
modified on
28/05/2026
|
Université catholique de Louvain
Publication in Chemistry World: https://www.chemistryworld.com/news/salt-bridge-strategy-expands-access-to-pharmaceutical-cocrystals/4012629.article
Combining API in a dual-drug ternary cocrystal approach
Lixing Song, Koen Robeyns, Nikolay Tumanov, Johan Wouters and Tom…
modified on
06/12/2024
|
Institute of Condensed Matter and Nanosciences
Researchers at UCLouvain, including the team of Françoise Van Bambeke (LDRI), have developed a new therapeutic strategy that directly targets the bacterial biofilms responsible for infections on orthopedic prostheses. In an experimental model, this new approach resulted in an average reduction of 99.9999% in bacterial load on infected…
modified on
20/01/2026
|
Louvain Drug Research Institute
Comment se connecter aux ressources électroniques à distance ?
modified on
05/02/2025
|
Bibliothèque de droit
THESES IN PROGRESSAuquière MarieEncapsulation of lipids and microARNs in extracellular vesicles for the treatment of multiple sclerosisDirectors : Anne des Rieux (ADDB/LDRI) and Giulio Muccioli 5BPBL/LDRI)Cheng ChenMetal-organic framework for oral antibody delivery for inflammatory bowel disease and colorectal cancer treatmentDirector : Ana…
modified on
17/08/2026
|
Louvain Drug Research Institute